Stay updated on AK104+Lenvatinib in Advanced Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the AK104+Lenvatinib in Advanced Hepatocellular Carcinoma Clinical Trial page.

Latest updates to the AK104+Lenvatinib in Advanced Hepatocellular Carcinoma Clinical Trial page
- CheckyesterdayChange DetectedThe page footer “Revision” value was updated from v3.5.2 to v3.5.3, indicating a platform release rather than a change to the clinical trial details shown on the page.SummaryDifference0.1%

- Check8 days agoChange DetectedRevision updated to v3.5.2; v3.5.0 was removed.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check37 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check44 days agoChange DetectedThe page footer now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.1%

- Check73 days agoChange DetectedThe page footer now shows Revision: v3.4.2, replacing the previous Revision: v3.4.1.SummaryDifference0.1%

- Check80 days agoChange DetectedSite revision updated from v3.4.0 to v3.4.1 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to AK104+Lenvatinib in Advanced Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK104+Lenvatinib in Advanced Hepatocellular Carcinoma Clinical Trial page.